Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chiara Pozzi

Showing results (21-30 of 38) with videos related to

Pageof 4
Sort By:
EMBO Molecular Medicine|April 8, 2022
BNT162b2 vaccine induces antibody release in saliva: a possible role for mucosal viral protection?Abbass Darwich, Chiara Pozzi, Giulia Fornasa, et al.
Nature Communications|June 3, 2020
Analysis of immune, microbiota and metabolome maturation in infants in a clinical trial of Lactobacillus paracasei CBA L74-fermented formulaPaola Roggero, Nadia Liotto, Chiara Pozzi, et al.
Vaccines|March 26, 2022
Short-Term Adverse Events and Antibody Response to the BNT162b2 SARS-CoV-2 Vaccine in 4156 Health Care ProfessionalsElena Azzolini, Lorenzo Maria Canziani, Antonio Voza, et al.
Nature Medicine|May 3, 2016
The EGFR-specific antibody cetuximab combined with chemotherapy triggers immunogenic cell deathChiara Pozzi, Alessandro Cuomo, Ilaria Spadoni, et al.
Life Science Alliance|February 16, 2022
mRNA COVID-19 vaccine booster fosters B- and T-cell responses in immunocompromised patientsElena Azzolini, Chiara Pozzi, Luca Germagnoli, et al.
Nutrients|January 28, 2021
Microbiome as Mediator of Diet on Colorectal Cancer Risk: The Role of Vitamin D, Markers of Inflammation and AdipokinesDavide Serrano, Chiara Pozzi, Silvia Guglietta, et al.
Neoplasia (New York, N.Y.)|October 24, 2022
Colorectal cancer, Vitamin D and microbiota: A double-blind Phase II randomized trial (ColoViD) in colorectal cancer patientsFederica Bellerba, Davide Serrano, Johansson Harriet, et al.
Gastro Hep Advances|February 17, 2022
A 'Multiomic' Approach of Saliva Metabolomics, Microbiota, and Serum Biomarkers to Assess the Need of Hospitalization in Coronavirus Disease 2019Chiara Pozzi, Riccardo Levi, Daniele Braga, et al.
EMBO Molecular Medicine|July 21, 2025
PV-1: a novel molecular prognostic marker of distant metastases in various solid tumorsChiara Pozzi, Riccardo Sarti, Antonino Lo Cascio, et al.
Frontiers in Immunology|May 29, 2024
Effectiveness of different booster vaccine combinations against SARS-CoV-2 during a six-month follow-up in Mexico and ArgentinaArnulfo Garza-Silva, Diego Rivera-Salinas, Andrea Rivera-Cavazos, et al.
Pageof 4

Showing results (21-30 of 38) with videos related to

Sort By:
Pageof 4
EMBO Molecular Medicine|April 8, 2022
BNT162b2 vaccine induces antibody release in saliva: a possible role for mucosal viral protection?Abbass Darwich, Chiara Pozzi, Giulia Fornasa, et al.
Nature Communications|June 3, 2020
Analysis of immune, microbiota and metabolome maturation in infants in a clinical trial of Lactobacillus paracasei CBA L74-fermented formulaPaola Roggero, Nadia Liotto, Chiara Pozzi, et al.
Vaccines|March 26, 2022
Short-Term Adverse Events and Antibody Response to the BNT162b2 SARS-CoV-2 Vaccine in 4156 Health Care ProfessionalsElena Azzolini, Lorenzo Maria Canziani, Antonio Voza, et al.
Nature Medicine|May 3, 2016
The EGFR-specific antibody cetuximab combined with chemotherapy triggers immunogenic cell deathChiara Pozzi, Alessandro Cuomo, Ilaria Spadoni, et al.
Life Science Alliance|February 16, 2022
mRNA COVID-19 vaccine booster fosters B- and T-cell responses in immunocompromised patientsElena Azzolini, Chiara Pozzi, Luca Germagnoli, et al.
Nutrients|January 28, 2021
Microbiome as Mediator of Diet on Colorectal Cancer Risk: The Role of Vitamin D, Markers of Inflammation and AdipokinesDavide Serrano, Chiara Pozzi, Silvia Guglietta, et al.
Neoplasia (New York, N.Y.)|October 24, 2022
Colorectal cancer, Vitamin D and microbiota: A double-blind Phase II randomized trial (ColoViD) in colorectal cancer patientsFederica Bellerba, Davide Serrano, Johansson Harriet, et al.
Gastro Hep Advances|February 17, 2022
A 'Multiomic' Approach of Saliva Metabolomics, Microbiota, and Serum Biomarkers to Assess the Need of Hospitalization in Coronavirus Disease 2019Chiara Pozzi, Riccardo Levi, Daniele Braga, et al.
EMBO Molecular Medicine|July 21, 2025
PV-1: a novel molecular prognostic marker of distant metastases in various solid tumorsChiara Pozzi, Riccardo Sarti, Antonino Lo Cascio, et al.
Frontiers in Immunology|May 29, 2024
Effectiveness of different booster vaccine combinations against SARS-CoV-2 during a six-month follow-up in Mexico and ArgentinaArnulfo Garza-Silva, Diego Rivera-Salinas, Andrea Rivera-Cavazos, et al.
Pageof 4